BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3521708)

  • 1. Modulation of anti-tumour immunity and the effect of bacterial endotoxin on the growth of different syngeneic tumours from small inocula in mice.
    Kearney R; Harrop P
    Br J Exp Pathol; 1986 Jun; 67(3):371-81. PubMed ID: 3521708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of anti-tumour immunity induced by syngeneic mitomycin C-treated murine tumour cells.
    Kearney R; Harrop P
    Int J Cancer; 1984 Aug; 34(2):255-61. PubMed ID: 6432709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of tumour growth by endotoxin in serum from syngeneic tumour-bearing mice.
    Kearney R; Harrop P
    Br J Cancer; 1980 Oct; 42(4):559-67. PubMed ID: 7002195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific tumor immunity induced with mitomycin C-treated syngeneic tumor cells (MCT). Effects of carrageenan and trypan blue on MCT-induced immunity in mice.
    Wu RL; Kearney R
    J Natl Cancer Inst; 1980 Jan; 64(1):81-7. PubMed ID: 6928050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of carrageenan, PVP and tumour-bearer serum on immunity induced by excision or mitomycin C-treated tumour cells in mice.
    Kearney R; Wu RL; Orr F
    Br J Cancer; 1979 Jun; 39(6):648-58. PubMed ID: 444404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation between tumour resistance and delayed-type hypersensitivity to tumour-associated antigens in the mouse.
    Henderson DC; Parker D; Turk JL
    Immunology; 1980 Jan; 39(1):1-9. PubMed ID: 7380461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent effects of bacterial lipopolysaccharide on immunity to orally administered protein and particulate antigens in mice.
    Mowat AM; Thomas MJ; MacKenzie S; Parrott DM
    Immunology; 1986 Aug; 58(4):677-83. PubMed ID: 3488267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophages and resistance to tumours: influence of agents affecting macrophages and delayed-type hypersensitivity on resistance to tumours inducing concomitant immunity.
    Nelson M; Nelson DS
    Aust J Exp Biol Med Sci; 1978 Apr; 56(2):211-23. PubMed ID: 209776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed-type hypersensitivity induced in immunodeficient mice with syngeneic modified self antigens: a suggestive model of autoimmune response.
    Tarcic N; Naor D
    Eur J Immunol; 1982 Nov; 12(11):961-6. PubMed ID: 6983970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of delayed-type hypersensitivity IV. Antigen-specific suppressor cells for delayed-type hypersensitivity induced by lipopolysaccharide and sheep erythrocytes in mice.
    Gill HK; Liew FY
    Eur J Immunol; 1979 Feb; 9(2):101-6. PubMed ID: 312202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies in the enhancement of tumour immunity by coupling strong antigens to tumour cells ('heterogenization of tumours'). Helper T cell clones against PPD help other T cells mount anti-tumour responses to PPD-coupled tumour cells.
    Sia DY; Lachmann PJ; Leung KN
    Immunology; 1984 Apr; 51(4):755-63. PubMed ID: 6200428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase by bacterial lipopolysaccharide of antibody production in mice rendered hyporesponsive to lysozyme.
    Hraba T; Madar J
    Folia Biol (Praha); 1989; 35(4):229-37. PubMed ID: 2691285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect Escherichia coli lipopolysaccharide (endotoxin) on the graft-versus-host reaction in mice (IV).
    Skopinska E
    Ann Med Sect Pol Acad Sci; 1976; 21(4):185-96. PubMed ID: 15368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors.
    Knisely TL; Luckenbach MW; Fischer BJ; Niederkorn JY
    J Immunol; 1987 Jun; 138(12):4515-23. PubMed ID: 3108394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses to soluble tumor antigens in various stages of tumor growth.
    Brannen GE; Santos GW
    Invest Urol; 1975 Sep; 13(2):79-84. PubMed ID: 1184342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the induction of delayed-type and contact hypersensitivity by calcitonin gene-related peptide.
    Asahina A; Hosoi J; Beissert S; Stratigos A; Granstein RD
    J Immunol; 1995 Apr; 154(7):3056-61. PubMed ID: 7897198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
    Miller SD; Butler LD
    J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ecology of danger-dependent cytokine-boosted spontaneous abortion in the CBA x DBA/2 mouse model. I. Synergistic effect of LPS and (TNF-alpha + IFN-gamma) on pregnancy loss.
    Clark DA; Manuel J; Lee L; Chaouat G; Gorczynski RM; Levy GA
    Am J Reprod Immunol; 2004 Dec; 52(6):370-8. PubMed ID: 15663602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of non-specific resistance and specific immune response against tumours in mice by synthetic muramyl dipeptide.
    Nĕmecková S; Bubeník J; Jezek J; Zaoral M
    Folia Biol (Praha); 1982; 28(5):327-33. PubMed ID: 7173449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro.
    Lynch DH; Gurish MF; Daynes RA
    Immunology; 1982 Sep; 47(1):49-59. PubMed ID: 6981587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.